Fig. 6.

Proportion of AK lesions by severity ^a(according to Olsen et al. [12]) at a baseline and b 8 weeks after the end of treatment (intent-to-treat population). ^a 5-FU/SA 5-fluorouracil 0.5%/salicylic acid 10%, AK actinic keratosis